Oculofaciocardiodental syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

X-linked dominant (affected mother)

Oculofaciocardiodental syndrome (OFCD syndrome) is a rare genetic disorder that primarily affects the eyes, face, heart, and teeth. It is inherited in an X-linked dominant manner and is caused by mutations in the BCOR gene.

Signs and Symptoms[edit | edit source]

Individuals with OFCD syndrome typically present with a range of symptoms that can vary in severity. Common features include:

Genetics[edit | edit source]

OFCD syndrome is caused by mutations in the BCOR gene, which is located on the X chromosome. The BCOR gene provides instructions for making a protein that is involved in the regulation of gene expression. Mutations in this gene disrupt normal development, leading to the various features of the syndrome.

Diagnosis[edit | edit source]

Diagnosis of OFCD syndrome is based on clinical evaluation, identification of characteristic physical findings, and genetic testing to detect mutations in the BCOR gene. Prenatal diagnosis may be possible if the mutation in the family is known.

Treatment[edit | edit source]

There is no cure for OFCD syndrome, and treatment is symptomatic and supportive. Management may involve a team of specialists, including ophthalmologists, cardiologists, dentists, and genetic counselors. Regular monitoring and early intervention can help manage the symptoms and improve the quality of life for affected individuals.

Epidemiology[edit | edit source]

OFCD syndrome is extremely rare, with only a few dozen cases reported in the medical literature. It primarily affects females, as males with the condition are often more severely affected and may not survive to birth.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

-


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD